564 related articles for article (PubMed ID: 32413966)
1. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
2. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
3. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
4. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
5. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
[TBL] [Abstract][Full Text] [Related]
6. γδ T cells and their potential for immunotherapy.
Wu YL; Ding YP; Tanaka Y; Shen LW; Wei CH; Minato N; Zhang W
Int J Biol Sci; 2014; 10(2):119-35. PubMed ID: 24520210
[TBL] [Abstract][Full Text] [Related]
7. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
9. Harnessing γδ T cells in anticancer immunotherapy.
Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L
Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
11. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
[TBL] [Abstract][Full Text] [Related]
12. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
Paul S; Lal G
Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
[TBL] [Abstract][Full Text] [Related]
13. Role of gammadelta T lymphocytes in tumor defense.
Zocchi MR; Poggi A
Front Biosci; 2004 Sep; 9():2588-604. PubMed ID: 15358583
[TBL] [Abstract][Full Text] [Related]
14. γδ T cell responses: How many ligands will it take till we know?
Vermijlen D; Gatti D; Kouzeli A; Rus T; Eberl M
Semin Cell Dev Biol; 2018 Dec; 84():75-86. PubMed ID: 29402644
[TBL] [Abstract][Full Text] [Related]
15. Current progress in γδ T-cell biology.
Hao J; Wu X; Xia S; Li Z; Wen T; Zhao N; Wu Z; Wang P; Zhao L; Yin Z
Cell Mol Immunol; 2010 Nov; 7(6):409-13. PubMed ID: 21042298
[TBL] [Abstract][Full Text] [Related]
16. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
[TBL] [Abstract][Full Text] [Related]
17. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
Chan KF; Duarte JDG; Ostrouska S; Behren A
Front Immunol; 2022; 13():894315. PubMed ID: 35880177
[TBL] [Abstract][Full Text] [Related]
18. Anti-lymphoma effect of gammadelta T cells.
Kunzmann V; Wilhelm M
Leuk Lymphoma; 2005 May; 46(5):671-80. PubMed ID: 16019504
[TBL] [Abstract][Full Text] [Related]
19. γδ T cells as a potential tool in colon cancer immunotherapy.
Ramutton T; Buccheri S; Dieli F; Todaro M; Stassi G; Meraviglia S
Immunotherapy; 2014; 6(9):989-99. PubMed ID: 25341120
[TBL] [Abstract][Full Text] [Related]
20. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]